Demcizumab (Anti-DLL4)
Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.
| Trivial name | OMP 21M18; Human Anti-TNFRSF10B Recombinant Antibody |
| Catalog Number | A2520 |
| CAS# | 1243262-17-0 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/demcizumab-anti-dll4.html |